Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions

International Journal of Cancer

Volumn 84, Issue 2, 1999, Pages 160-168

  Moretti, Silvia ^a   Pinzi, Cinzia ^b   Spallanzani, Adelina ^b   Berti, Emilio ^c   Chiarugi, Alessandra ^b   Mazzoli, Sandra ^d   Fabiani, Massimo ^e   Vallecchi, Carlo ^b   Herlyn, Meenhard ^f  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE ANTIBODY; CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; RECEPTOR ANTIBODY; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; METASTASIS; NEVUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR VOLUME;

ADULT; AGED; CYTOKINES; DISEASE PROGRESSION; FEMALE; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MALE; MELANOCYTES; MIDDLE AGED; NEOPLASM PROTEINS; NEVUS; RECEPTORS, CYTOKINE; SKIN NEOPLASMS;

EID: 0033046920     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990420)84:2<160::AID-IJC12>3.0.CO;2-R     Document Type: Article

References (37)

1. AHMED, A.A., NORDLIND, K., HEBDLAD, M., LAGERHOLM, B., SCHULTZBERG, M. and LIDÉN, S., Interleukin (IL)-1α and -1β, IL-6-, and tumor necrosis factor-α-like immunoreactivities in human common and dysplastic nevocellular nevi and malignant melanoma. Amer. J. Dermatopathol., 17, 222-229 (1995).
2. ALBINO, A.P., DAVID, B.M. and NANUS, D.M., Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res., 51, 4815-4820 (1991).
3. ALILECHE, A., PLAISANCE, S., HAN, D.S., RUBINSTEIN, E., MINGARI, C., BELLOMO, R., JASMIN, C. and AZZARONE, B., Human melanoma cell line M14 secretes a functional interleukin 2. Oncogene, 8, 1791-1796 (1993).
4. AMSTRONG, C.A., TARA, D.C., HART, C.E., KOCK, A., LUGER, T.A. and ANSEL, J.C., Heterogeneity of cytokine production by human malignant melanoma cells. Exp. Dermatol., 1, 37-45 (1992).
5. BENNICELLI, J.L. and GUERRY, IV, D., Production of multiple cytokines in human melanomas. Exp. Dermatol., 2, 186-190 (1993).
6. CIOTTI, P., RAINERO, M.L., NICOLO, G., SPINA, B., GARRE, E., CASABONA, F., SANTI, P.L. and BIANCHI-SCARRA, G., Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh biopsy specimens. Melanoma Res., 5, 41-47 (1995).
7. CLARK, W.H., JR., ELDER, D.E. and VAN HORN, M., The biologic forms of malignant melanoma. Hum. Pathol., 17, 443-450 (1986).
8. COLOMBO, M.P, MACCALLI, C., MATTEI, S., MELANI, C., RADDRIZZANI, M. and PARMIANI, G., Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines. Melanoma Res., 2, 181-189 (1992).
9. DE WIT, P.E.J., MORETTI, S., KOENDERS, P.G., WETERMAN, M.A.J., VAN MUIJEN, G.N.P., GIANNOTTI, B. and RUITER, D.J., Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. J. invest. Dermatol., 99, 168-173 (1992).
10. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBE, K.P., LEVITSKY, H., BROSE, K., JACKSON, V., MAMEDA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
11. FLEISCHMANN, R., From white spots to stem cells: the role of the kit receptor in mammalian development. Trends Genet., 9, 285-290 (1993).
12. GIEBEL, L.D. and SPRITZ, R.A., Mutation of the kit (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc. nat. Acad. Sci. (Wash.), 88, 8696-8699 (1991).
13. GRABBE, J., WALKER, P., DIPPEL, E. and CZARNETZKI, B.M., Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch. Dermatol. Res., 287, 78-84 (1994).
14. GUTMAN, M., SINGH, R.K, SIE, K., BUCANA, C.D. and FIDLER, I.J., Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res., 55, 2470-2475 (1995).
15. HERLYN, M., Molecular and cellular biology of melanoma, pp. 54-64, R.G. Landes, Austin, TX (1993).
16. KOCH, A.E., POLVERINI, P.J., KUNKEL, S.L., HARLOW, L.A., DIPIETRO, L.A., ELNER, V.M., ELNER, S.G. and STRIETER, R.M., Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 258, 1798-1801 (1992).
17. LETARTE, M., GREAVES, A. and VERA, S., CD105 (endoglin) cluster report. In: S. Schlossman, L. Boumsell, W. Gliks, J.M. Harlan, T. Kishimoto, G. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.F. Tedder and R.F. Todd (eds.), Leukocyte typing V - white cell differentiation antigens (Vol. 2, Endothelial cell antigens), pp. 1756-1759, Oxford University Press, Oxford, UK (1995).
18. LU, C. and KERBEL, R.S., Interleukin 6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol., 120, 1281-1288 (1993).
19. LUDWIG, A., PETERSEN, F., ZAHN, S., GOTZE, O., SCHRODER, J.M., FLAD, H.D. and BRANDT, E., The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood, 90, 4588-4597 (1997).
20. MASSAGUÉ, J., TGF-β signaling: receptors, transducers, and Mad proteins. Cell, 85, 947-950 (1996).
21. MATTEI, S., COLOMBO, M.P., MELANI, C., SILVANI, A., PARMIANI, G. and HERLYN, M., Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer, 56, 853-857 (1994).
22. MCMILLAN, D.N., KERHOAN, N.M., FLETT, M.E., HEYS, S.D., DEEHAN, D.J., SEWELL, H.F., WALKER, F. and EREMIN, O., Interleukin 2 receptor expression and interleukin 2 localization in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumor cell proliferation. Int. J. Cancer, 60, 766-772 (1995).
23. MORETTI, S., PINZI, C., BERTI, E., SPALLANZANI, A., CHIARUGI, A., BODDI, V., REALI, U.M. and GIANNOTTI, B., In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR, and beta 3 integrin expression. Melanoma Res., 7, 313-321 (1997).
24. NATALI, P.G., NICOTRA, M.R., WINKLER, A.B., CAVALIERE, R., BIGOTTI, A. and ULLRICH, A., Progression of human cutaneous melanoma is associated with loss of expression of c-kit protooncogene receptor. Int. J. Cancer, 52, 197-201 (1992).
25. NORGAUER, J., METZNER, B. and SCHRAUFSTATTER, I., Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol., 156, 1132-1137 (1996).
26. PAQUET, P. and PIÉRARD, G.E., Interleukin-6 and the skin. Int. Arch. Allergy Immunol., 109, 308-317 (1996).
27. REED, J.A., MCNUTT, S.C., PRIETO, V.G. and ALBINO, A.P., Expression of transforming growth factor beta 2 in malignant melanoma correlates with the depth of tumor invasion. Amer. J. Pathol., 145, 97-104 (1994).
28. RIZZINO, A., Transforming growth factor β: multiple effects on cell differentiation and extracellular matrices. Develop. Biol., 130, 411-422 (1988).
29. RODECK, U., HOSSLER, A., GRAEVEN, U., FOX, F.E., NOWELL, P.C., KNABBE, C. and KAN, C., Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res., 54, 575-581 (1994).
30. RODECK, U., MELBER, K., KATH, R., MENSEN, H.S., VARELLO, M., ATKINSON, B. and HERLYN, M., Constitutive expression of multiple growth factor genes by normal melanoma cells but not normal melanocytes. J. invest. Dermatol., 97, 20-26 (1991).
31. SCHADENDORF, D., MOLLER, A., ALGERMISSEN, B., WORM, M., STICHERLING, M. and CZARNETZKI, B.M., IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 151, 2667-2675 (1993).
32. SCHMID, P., ITIN, P. and RUFLI, T., In situ analysis of transforming growth factor-beta (TGF-β1, TGF-β2, TGF-β3), and TGF-β type II receptor expression in malignant melanoma. Carcinogenesis, 16, 1499-1503 (1995).
33. TAKAHASHI, H., SAITOH, K., KISHI, H. and PARSONS, P.G., Immunohistochemistry localization of stem cell factor (SCF) with comparison of its receptor c-kit proto-oncogene product (c-kit) in melanocytic tumours. Virchows Arch., 427, 283-288 (1995).
34. TYLER, D.S., FRANCIS, D.M., FREDERICK, M., TRAN, A.H., ORDONEZ, N.G., SMITH, J.L., ETON, O., ROSS, M. and GRIMM, E.A., Interleukin-1 production in tumor cells of human melanoma surgical specimens. J. Interferon Cytokine Res., 15, 331-340 (1995).
35. UICC (INTERNATIONAL UNION AGAINST CANCER), TNM classifications (4th ed.), UICC, Geneva (1987).
36. VAN BELLE, P., RODECK, U., NUAMAH, I., HALPERN, A.C. and ELDER, D.E., Melanoma-associated expression of TGF-β isoforms. Amer. J. Pathol., 148, 1887-1894 (1996).
37. ZHOU, D., MUNSTER, G. and WINCHURCH, R.A., Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-β. FASEB J., 5, 2582-2585 (1991).